Assessment of functional status

• US 20080004509A1
• Filed: 06/11/2007
• Published: 01/03/2008
• Est. Priority Date: 06/09/2006
• Status: Abandoned Application

• Current Assignee: Cambridge University (Government of United Kingdom)
• Original Assignee: Cambridge University (Government of United Kingdom)
• Inventors: Blackwell, Andrew, Sahakian, Barbara
• Application Number:
  US11/808,561
• Publication Number:
  US 20080004509A1
• Time in Patent Office: Days
• US Class Current: 600/300
• CPC Class Codes: G09B 7/00 Electrically-operated teaching apparatus or devices working with questions and answers mechanically operated G09B3/00; computing arrangements G06F
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems

Abstract

This invention relates to methods of neurocognitive assessment and, in particular, to methods for assessing the ability of individuals, in particular, memory-impaired individuals, to perform daily activities (i.e. functional status).

Claims

1. A method of assessing the functional status of an individual comprising:

providing a visuospatial learning and memory score obtained from an assessment of a visuospatial learning and memory of said individual, and

determining from said score a functional status of said individual.

2. The method according to claim 1, further comprising assessing the visuospatial learning and memory of said individual to produce the visuospatial learning and memory score.

3. The method according to claim 1, wherein the individual has a reduced or impaired memory.

4. The method according to claim 1, wherein the functional status of the individual is expressed as a functional status score.

5. The method according to claim 1, wherein the functional status score is determined by relating the visuospatial learning and memory score of the individual with at least one metric.

6. The method according to claim 1, wherein the at least one metric is one of:

age, gender, IQ, ethnicity, level of education, genetic factors, medical history, current medication and current comorbid disorders.

7. The method according to claim 6, wherein the visuospatial learning and memory score of the individual is related to the at least one metric using an algorithm or model to produce a functional status score.

8. The method according to claim 2, wherein the visuospatial learning and memory is assessed using a paired associates learning test.

9. The method according to claim 8, wherein the paired associates learning test is an automated test configured to be conducted using a computer.

10. The method according to claim 9, wherein the paired associates learning test is a CANTAB-PAL test.

11. The method according to claim 2, further comprising administering a therapy to the individual.

12. The method according to claim 11, further comprising determining the functional status of said individual following said administration.

24. A computer-readable medium configured to perform the method of claim 1.

27. A computer system configured to perform the method according to claim 1.

13. A method of identifying a compound useful for improving a functional status of an individual having a reduced or impaired memory, the method comprising:

assessing a visuospatial learning and memory of an individual having a condition characterised by a reduced or impaired memory to produce a first visuospatial learning and memory score for the individual;

determining from said first score the functional status of said individual before administration of a test compound;

administering the test compound to the individual;

assessing the visuospatial learning and memory of said individual to produce a second visuospatial learning and memory score; and

determining from said second score the functional status of said individual following said administration.

15. The method according to claim 13, wherein an improvement in the functional status following said administration relative to before the administration is indicative that the compound is useful for improving the cognitive function of the individual having the reduced or impaired memory.

16. The method according to claim 13, wherein an improvement in said functional status following said administration relative to at least one control is indicative that the compound is useful for improving the cognitive function of the individual having the reduced or impaired memory.

17. The method according to claim 13, wherein the functional status of the individual is expressed as a functional status score.

18. The method according to claim 17, wherein the functional status score is determined by relating at least the first or second visuospatial learning and memory score of the individual to at least one metric.

19. The method according to claim 18, wherein the at least one metric is one of:

age, gender, IQ, ethnicity, level of education, genetic factors, medical history, current medication and current comorbid disorders.

20. The method according to claim 18, wherein at least the first or second visuospatial learning and memory score of the individual is related to the at least one metric using an algorithm or model to produce the functional status score.

21. The method according to claim 13, wherein the visuospatial learning and memory is assessed using a paired associates learning test.

22. The method according to claim 21, wherein the paired associates learning test is configured to be conducted using a computer.

23. The method according to claim 21, wherein the paired associates learning test is a CANTAB-PAL test.

25. A computer-readable medium configured to perform the method of claim 13.

28. A computer system configured to perform the method according to claim 13.

14. A method of identifying a compound for improving a functional status of an individual having a reduced or impaired memory, the method comprising:

providing a population of individuals having reduced or impaired memories;

assessing a visuospatial learning and memory of each of the individuals to produce a first visuospatial learning and memory score;

determining from said first score the functional status of each individual before an administration of a test compound;

administering the test compound to each individual;

assessing the visuospatial learning and memory of each individual to produce a second visuospatial learning and memory score; and

determining from said second score the functional status of each individual following said administration.

26. A computer-readable medium configured to perform the method of claim 14.

29. A computer system configured to perform the method according to claim 14.

30. A computer system comprising:

a processor configured to;

perform a visuospatial learning and memory test on a subject,

record a plurality of responses by the subject to the test,

calculate a visuospatial learning and memory score for the subject based on the plurality of responses, and

determine a functional status of the subject based on the visuospatial learning and memory score.

31. The computer system according to claim 30, wherein the processor is further configured to produce a functional status score.

32. The computer system according to claim 31, wherein the functional status score is to be displayed on a monitor.

33. The computer system according to claim 32, wherein the functional status score is to be recorded and/or stored in a data storage device.

34. A method for assessing a functional status, comprising:

assessing a plurality of individuals to determine a plurality of metrics for each of the individuals, wherein the metrics comprise physical characteristics of the individuals;

performing a visuospatial learning and memory test on each of the plurality of individuals to determine a visuospatial learning and memory score for each of the individuals; and

determining a functional status for each of the individuals based on the plurality of metrics and the visuospatial learning and memory score of each individual.

35. The method of claim 34, wherein the plurality of metrics further comprise mental characteristics of the individuals.

36. The method of claim 34, wherein the plurality of metrics further comprise health histories of the individuals.

37. The method of claim 34, further comprising:

identifying a subset of the individuals based on the functional status of the individuals;

administering a test compound to the subset of individuals;

performing a second visuospatial learning and memory test on each of the plurality of individuals in the subset to determine a second visuospatial learning and memory score for each of the individuals in the subset;

determining a post administration functional status for each of the individuals in the subset based on the plurality of metrics and the second visuospatial learning and memory score of each individual; and

determining the effect of the test compound on each of the individuals in the subset based on a difference between the individual'"'"'s functional status prior to the administration of the test compound and the individual'"'"'s post administration functional status.

38. The method of claim 37, further comprising determining the effect of the test compound based on the effect of the test compound on each of the individuals.

39. The method of claim 37, wherein the method is used to monitor the effects of the test compound.

40. The method of claim 39, further comprising basing prescription decisions on the monitored effects of the test compound.

41. A method for assessing a functional status, comprising:

determining a first functional status of a subject based on a plurality of metrics related to the subject and results of a visuospatial learning and memory test,

administering a test compound to the subject;

determining a second functional status for the subject based on the plurality of metrics and a second visuospatial learning and memory test performed following the administration of the test compound; and

determining the effect of the test compound on the subject based on a difference between the first functional status and the second functional status.

42. The method of claim 41, further comprising determining at least on additional functional status of the subject following at least one additional administration of the test compound.

43. The method of claim 42, further comprising monitoring the subject'"'"'s functional status.

44. The method of claim 43, further comprising determining prescription parameters based at least in part on the monitoring of the subject'"'"'s functional status.